Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
- PMID: 9438854
- DOI: 10.1126/science.279.5350.577
Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors
Abstract
Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal tumors in the human digestive tract, but their molecular etiology and cellular origin are unknown. Sequencing of c-kit complementary DNA, which encodes a proto-oncogenic receptor tyrosine kinase (KIT), from five GISTs revealed mutations in the region between the transmembrane and tyrosine kinase domains. All of the corresponding mutant KIT proteins were constitutively activated without the KIT ligand, stem cell factor (SCF). Stable transfection of the mutant c-kit complementary DNAs induced malignant transformation of Ba/F3 murine lymphoid cells, suggesting that the mutations contribute to tumor development. GISTs may originate from the interstitial cells of Cajal (ICCs) because the development of ICCs is dependent on the SCF-KIT interaction and because, like GISTs, these cells express both KIT and CD34.
Similar articles
-
Mutations in exon 11 of c-Kit occur preferentially in malignant versus benign gastrointestinal stromal tumors and do not occur in leiomyomas or leiomyosarcomas.Am J Pathol. 1999 Jan;154(1):53-60. doi: 10.1016/S0002-9440(10)65250-9. Am J Pathol. 1999. PMID: 9916918 Free PMC article.
-
Gastrointestinal stromal tumors: their origin and cause.Int J Clin Oncol. 2001 Feb;6(1):1-5. doi: 10.1007/pl00012072. Int J Clin Oncol. 2001. PMID: 11706520 Review.
-
A novel gain-of-function mutation of c-kit gene in gastrointestinal stromal tumors.Gastroenterology. 1998 Nov;115(5):1090-5. doi: 10.1016/s0016-5085(98)70079-4. Gastroenterology. 1998. PMID: 9797363
-
c-kit mutations in gastrointestinal stromal tumors occur preferentially in the spindle rather than in the epithelioid cell variant.Mod Pathol. 2002 Feb;15(2):125-36. doi: 10.1038/modpathol.3880504. Mod Pathol. 2002. PMID: 11850541
-
Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis.Arch Pathol Lab Med. 2006 Oct;130(10):1466-78. doi: 10.5858/2006-130-1466-GSTROM. Arch Pathol Lab Med. 2006. PMID: 17090188 Review.
Cited by
-
Wandering small intestinal stromal tumor: A case report.World J Clin Cases. 2022 Oct 16;10(29):10622-10628. doi: 10.12998/wjcc.v10.i29.10622. World J Clin Cases. 2022. PMID: 36312500 Free PMC article.
-
Advances in sarcoma diagnostics and treatment.Oncotarget. 2017 Jan 24;8(4):7068-7093. doi: 10.18632/oncotarget.12548. Oncotarget. 2017. PMID: 27732970 Free PMC article. Review.
-
Management of gastrointestinal stromal tumors: looking beyond the knife. An update on the role of adjuvant and neoadjuvant imatinib therapy.J Gastrointest Cancer. 2012 Dec;43(4):547-52. doi: 10.1007/s12029-012-9423-0. J Gastrointest Cancer. 2012. PMID: 22847491 Review.
-
Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.Drug Des Devel Ther. 2016 Aug 1;10:2443-59. doi: 10.2147/DDDT.S89114. eCollection 2016. Drug Des Devel Ther. 2016. PMID: 27536065 Free PMC article. Review.
-
Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants.PLoS One. 2013 Apr 18;8(4):e62119. doi: 10.1371/journal.pone.0062119. Print 2013. PLoS One. 2013. PMID: 23637977 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous